# The University of Texas MD Anderson Cancer Center

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/the-university-of-texas-md-anderson-cancer-center/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 77.7 |
| Citations | 34,647,187 |
| City | Houston |
| Country | US |
| Description | The University of Texas MD Anderson Cancer Center is a research organisation in Houston, US. OpenAlex records 171,852 works and 34,647,187 citations for it. 33,425 researchers list it as their most recent affiliation. |
| Homepage | https://www.mdanderson.org |
| OpenAlex ID | https://openalex.org/I1343551460 |
| Region | Texas |
| Researchers | 33,425 |
| ROR ID | https://ror.org/04twxam07 |
| Type | healthcare |
| Works | 171,852 |

## University collaborators

Showing 10 of 20.

- [Johns Hopkins University](https://scholariq.org/institutions/johns-hopkins-university/)
- [Institut Gustave Roussy](https://scholariq.org/institutions/institut-gustave-roussy/)
- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)
- [The Ohio State University](https://scholariq.org/institutions/the-ohio-state-university/)
- [Dana-Farber Cancer Institute](https://scholariq.org/institutions/dana-farber-cancer-institute/)
- [Massachusetts General Hospital](https://scholariq.org/institutions/massachusetts-general-hospital/)
- [Bristol-Myers Squibb (United States)](https://scholariq.org/institutions/bristol-myers-squibb-united-states/)
- [University of Pennsylvania](https://scholariq.org/institutions/university-of-pennsylvania/)
- [Johns Hopkins Medicine](https://scholariq.org/institutions/johns-hopkins-medicine/)
- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

## University papers

Showing 12 of 1010.

- [Robust enumeration of cell subsets from tissue expression profiles](https://scholariq.org/papers/robust-enumeration-of-cell-subsets-from-tissue-expression-profiles/)
- [Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010](https://scholariq.org/papers/global-and-regional-mortality-from-235-causes-of-death-for-20-age-groups-in-1990/)
- [Signatures of mutational processes in human cancer](https://scholariq.org/papers/signatures-of-mutational-processes-in-human-cancer/)
- [Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer](https://scholariq.org/papers/nivolumab-versus-docetaxel-in-advanced-nonsquamous-non-small-cell-lung-cancer/)
- [Integrated genomic analyses of ovarian carcinoma](https://scholariq.org/papers/integrated-genomic-analyses-of-ovarian-carcinoma/)
- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)
- [Comprehensive genomic characterization defines human glioblastoma genes and core pathways](https://scholariq.org/papers/comprehensive-genomic-characterization-defines-human-glioblastoma-genes-and-core/)
- [Comprehensive molecular characterization of gastric adenocarcinoma](https://scholariq.org/papers/comprehensive-molecular-characterization-of-gastric-adenocarcinoma/)
- [Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer](https://scholariq.org/papers/human-papillomavirus-and-survival-of-patients-with-oropharyngeal-cancer/)
- [The Immune Landscape of Cancer](https://scholariq.org/papers/the-immune-landscape-of-cancer/)
- [Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/nivolumab-versus-everolimus-in-advanced-renal-cell-carcinoma/)
- [Definition and classification of cancer cachexia: an international consensus](https://scholariq.org/papers/definition-and-classification-of-cancer-cachexia-an-international-consensus/)

## University researchers

Showing 15 of 35.

- [Keunchil Park](https://scholariq.org/researchers/keunchil-park/)
- [John V. Heymach](https://scholariq.org/researchers/john-v-heymach/)
- [Suresh T. Chari](https://scholariq.org/researchers/suresh-t-chari/)
- [George R. Blumenschein](https://scholariq.org/researchers/george-r-blumenschein/)
- [Alastair M. Thompson](https://scholariq.org/researchers/alastair-m-thompson/)
- [Henry M. Kuerer](https://scholariq.org/researchers/henry-m-kuerer/)
- [James C. Yao](https://scholariq.org/researchers/james-c-yao/)
- [Jing Wang](https://scholariq.org/researchers/jing-wang-2/)
- [Ju‐Seog Lee](https://scholariq.org/researchers/ju-seog-lee/)
- [Bruce D. Minsky](https://scholariq.org/researchers/bruce-d-minsky/)
- [Anita Deswal](https://scholariq.org/researchers/anita-deswal/)
- [Bonnie S. Glisson](https://scholariq.org/researchers/bonnie-s-glisson/)
- [Garth Powis](https://scholariq.org/researchers/garth-powis/)
- [Lauren A. Byers](https://scholariq.org/researchers/lauren-a-byers/)
- [Jianjun Zhang](https://scholariq.org/researchers/jianjun-zhang-2/)

## University top topics

Showing 8 of 25.

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.